✦ LIBER ✦

The basics of preclinical drug development for neurodegenerative disease indications

✍ Scribed by Karen L Steinmetz; Edward G Spack

Book ID: 115009604
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 365 KB
Volume: 9
Category: Article
ISSN: 1471-2377
DOI: 10.1186/1471-2377-9-s1-s2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

List of Drugs in Development for Neurode

List of Drugs in Development for Neurodegenerative Diseases: Update June 2010

✍ Pogačić Kramp, Vanda; Herrling, Paul 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 248 KB

Meeting the unique challenges of drug di

Meeting the unique challenges of drug discovery for neurodegenerative diseases

✍ Diana W Shineman; Howard M Fillit 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 179 KB

Neuroimmunophilins: A novel drug therapy

Neuroimmunophilins: A novel drug therapy for the reversal of neurodegenerative disease?

✍ M.O. Poulter; K.B. Payne; J.P. Steiner 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Discovery and Preclinical Validation of

Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

✍ Sirota, M.; Dudley, J. T.; Kim, J.; Chiang, A. P.; Morgan, A. A.; Sweet-Cordero, 📂 Article 📅 2011 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 409 KB

Preclinical and clinical challenges in t

Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease

✍ Carol A Scorer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Preclinical development of TLR ligands a

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections

✍ Zhang, Xiaoyong; Kraft, Anke; Broering, Ruth; Schlaak, Joerg F; Dittmer, Ulf; Lu 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 438 KB